Literature DB >> 8687424

Mutant mtDNA at 1555 A to G in 12S rRNA gene and hypersusceptibility of mitochondrial translation to streptomycin can be co-transferred to rho 0 HeLa cells.

K Inoue1, D Takai, A Soejima, K Isobe, T Yamasoba, Y Oka, Y Goto, J Hayashi.   

Abstract

Human skin fibroblast line 95-119, which had been isolated from the mother of a Japanese patient with aminoglycoside-induced deafness and a 1555 A to G mutation at 12S rRNA gene in mitochondrial DNA (mtDNA), was used to investigate the relationship between the 1555 mtDNA mutation and its pathogenicity. By the intercellular transfer of mtDNA with or without the 1555 mutation to mtDNA-less (rho 0) HeLa cells, we isolated cybrid clones and found that the mitochondrial translation in a cybrid clone repopulated with the homoplasmic 1555 mutation showed the highest susceptibility to streptomycin. These observations suggest that the genotype of the mutant mtDNA and the phenotype of hypersusceptibility to streptomycin observed in 95-119 fibroblasts were co-transferred simultaneously to rho 0 HeLa cells, supporting the idea that the homoplasmic 1555 mtDNA mutation is involved in the pathogenesis leading to aminoglycoside-induced hearing loss.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687424     DOI: 10.1006/bbrc.1996.0923

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Transmitochondrial mice: proof of principle and promises.

Authors:  M Hirano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 2.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

3.  The use of mitochondria-targeted endonucleases to manipulate mtDNA.

Authors:  Sandra R Bacman; Sion L Williams; Milena Pinto; Carlos T Moraes
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

4.  [Mitochondrial A1555G mutation. Molecular genetic diagnosis in sporadic cases of non-syndromic hearing impairment].

Authors:  S Kupka; B Bodden-Kamps; M Baur; H P Zenner; M Pfister
Journal:  HNO       Date:  2004-11       Impact factor: 1.284

5.  Hearing in 44-45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study.

Authors:  Shamima Rahman; Russell Ecob; Harry Costello; Mary G Sweeney; Andrew J Duncan; Kerra Pearce; David Strachan; Andrew Forge; Adrian Davis; Maria Bitner-Glindzicz
Journal:  BMJ Open       Date:  2012-01-05       Impact factor: 2.692

6.  Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and non-syndromic hearing loss.

Authors:  Hui Zhao; Wie-Yen Young; Qingfeng Yan; Ronghua Li; Juyang Cao; Qiuju Wang; Xiaoming Li; Jennifer L Peters; Dongyi Han; Min-Xin Guan
Journal:  Nucleic Acids Res       Date:  2005-02-18       Impact factor: 16.971

7.  Antibiotic stress-induced modulation of the endoribonucleolytic activity of RNase III and RNase G confers resistance to aminoglycoside antibiotics in Escherichia coli.

Authors:  Wooseok Song; Yong-Hak Kim; Se-Hoon Sim; Soonhye Hwang; Jung-Hyun Lee; Younghoon Lee; Jeehyeon Bae; Jihwan Hwang; Kangseok Lee
Journal:  Nucleic Acids Res       Date:  2014-01-30       Impact factor: 16.971

Review 8.  Role of Oxidative Stress and Antioxidants in Acquired Inner Ear Disorders.

Authors:  Megumi Kishimoto-Urata; Shinji Urata; Chisato Fujimoto; Tatsuya Yamasoba
Journal:  Antioxidants (Basel)       Date:  2022-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.